Eli Lilly Aktie
WKN: 858560 / ISIN: US5324571083
|
05.08.2026 12:49:32
|
Eli Lilly And Co. Bottom Line Advances In Q2
(RTTNews) - Eli Lilly And Co. (LLY) revealed a profit for its second quarter that Increases, from last year
The company's bottom line came in at $7.095 billion, or $7.94 per share. This compares with $5.661 billion, or $6.29 per share, last year.
Excluding items, Eli Lilly And Co. reported adjusted earnings of $7.493 billion or $8.38 per share for the period.
The company's revenue for the period rose 47.7% to $22.974 billion from $15.558 billion last year.
Eli Lilly And Co. earnings at a glance (GAAP) :
-Earnings: $7.095 Bln. vs. $5.661 Bln. last year. -EPS: $7.94 vs. $6.29 last year. -Revenue: $22.974 Bln vs. $15.558 Bln last year.
-Guidance: Full year EPS guidance: $ 35.50 To $ 36.50 Full year revenue guidance: $ 85 B To $ 87 B
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Eli Lilly
Analysen zu Eli Lilly
| 04.02.26 | Eli Lilly Buy | Goldman Sachs Group Inc. | |
| 20.12.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
| 31.10.24 | Eli Lilly Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
| Eli Lilly | 1 026,60 | 1,66% |
|